LAUER REGAN J 4
4 · ImmunityBio, Inc. · Filed Dec 19, 2023
Insider Transaction Report
Form 4
LAUER REGAN J
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-15+21,030→ 74,932 total - Exercise/Conversion
Restricted Stock Units
2023-12-15−21,030→ 21,031 total→ Common Stock (21,030 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
- [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units ("RSUs") will vest as follows: 1/3rd of the RSUs subject to the award shall vest June 15, 2023, 1/3rd of the RSUs subject to the award shall vest December 15, 2023, and 1/3rd of the RSUs subject to the award shall vest December 15, 2024 such that the award shall be fully vested on December 15, 2024.